Women's Issues and Epilespy

NYU has been a leader in studies of women with epilepsy, with a particular focus on care of women during their childbearing years.  NYU was one of 3 centers that conducted the WEPOD study (Women with Epilepsy: Pregnancy Outcome and Delivery). This study compared women who were attempting pregnancy with matched controls, and demonstrated for the first time that women with epilepsy do not have specific problems with fertility, and that the rate of miscarriage is no higher in women with epilepsy compared to controls.

NYU is also involved in the ongoing multicenter MONEAD (Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs) study and contributes to its administrative core. This controlled study will provide vital information about risks to women with epilepsy during pregnancy including risks of pregnancy complications, and will monitor children born to women with epilepsy for up to 6 years, to explore whether there are any specific developmental issues. NYU is also collaborating with other researchers to investigate issues and complications related to use of specific antiepileptic drugs during pregnancy.